Diseases as network perturbations

Current Opinion in Biotechnology

Volumn 21, Issue 4, 2010, Pages 566-571

  del Sol, Antonio ^a   Balling, Rudi ^a   Hood, Lee ^b   Galas, David ^b  

^a UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PROCESS; CELLULAR NETWORK; COMPLEX BEHAVIOR; COMPLEX BIOLOGICAL SYSTEMS; HUMAN DISEASE; INDIVIDUAL COMPONENTS; NETWORK ANALYSIS; NETWORK REPRESENTATION; NETWORK-BASED; PATHOPHYSIOLOGY;

CELLULAR NEURAL NETWORKS; ELECTRIC NETWORK ANALYSIS;

BIOLOGICAL SYSTEMS;

CELL ACTIVITY; CYTOLOGY; DISEASE ACTIVITY; DISEASE COURSE; DNA DAMAGE; DRUG DESIGN; DRUG RESEARCH; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE REGULATORY NETWORK; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MATHEMATICAL MODEL; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; NONHUMAN; PATHOGENESIS; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW; SYSTEMS BIOLOGY;

DISEASE; DRUG DESIGN; GENE REGULATORY NETWORKS; HUMANS;

EID: 77956652450     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2010.07.010     Document Type: Review

References (40)

1. Galas D., Hood L. Systems biology and emerging technologies will catalyze the transition from reactive medicine to predictive, personalized, preventive and participatory (P4) medicine. IBC 2009, 6:1-4.
2. Miller-Jensen K., Janes K.A., Brugge J.S., Lauffenburger D.A. Common effectors processing mediates cell-specific responses to stimuli. Nature 2007, 448:604-609.
3. Geva-Zatorsky N., Dekel E., Cohen A.A., Danon T., Cohen L., Alon U. Protein dynamics in drug combinations: a linear superposition of individual-drug responses. Cell 2010, 140:643-651.
4. Raj A., Oudenaarden Nature, nurture, or chance: stochastic gene expression and its consequences. Cell 2008, 135:216-226.
5. Spencer S.L., Gaudet S., Albeck J.G., Burke J.M., Sorger P.K. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 2009, 459:428-432.
6. Chang H.H., Hemberg M., Barahona M., Ingber D.E., Huang S. Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 2008, 453:544-547.
7. Kauffman S.A. Metabolic stability and epigenesis in randomly constructed genetic nets. J Theor Biol 1969, 22:437-467.
8. Kauffman S.A. Homeostasis and differentiation in random genetic control networks. Nature 1969, 224:177-178.
9. Huang S., Eichler G., Bar-Yam Y., Ingber D.E. Cell fates as high-dimensional attractor states of a complex gene regulatory network. Phys Rev Lett 2005, 94:128701.
10. Huang A.C., Hu L., Kauffman S.A., Zhang W., Shmulevich I. Using cell fate attractors to uncover transcriptional regulation of HL60 neutrophil differentiation. BMC Syst Biol 2009, 3:20.
11. Calzone L., Tournier L., Fourquet S., Thiefrry D., Zhivotovsky B., Barillot E., Zinovyev A Mathematical modelling of cell-fate decision in response to death receptor engagement. PLoS Comput Biol 2010, 6:e1000702.
12. Morris M.K., Saez-Rodriguez J., Sorger P.K., Lauffenburger D.A. Logic-based models for the analysis of cell signaling networks. Biochemistry 2010, 49:3216-3224.
13. Stelling J., Sauer U., Szallasi Z., Doyle F.J., Doyle J. Robustness of cellular functions. Cell 2004, 118:675-685.
14. Kitano H., Oda K., Kumura T., Matsuoka Y., Csete M., Doyle J., Muramatsu M. Metabolic syndrome and robustness tradeoff. Diabetes 2004, 53:S6-S14.
15. Kitano H. Tumour tactics. Nature 2003, 426:125.
16. Zhu X., Gerstein M., Snyder M. Getting connected: analysis and principles of biological networks. Genes Dev 2007, 21:1010-1024.
17. Pan Y., Tsai C.-J., Ma B., Nussinov R. How do transcription factors select specific binding site in the genome. Nat Struct Biol 2009, 16:1118-1120.
18. Ma B., Tsai C.-J., Pan Y., Nussinov R. Why does binding of proteins to DNA or proteins to proteins not necessarily spell function?. ACS Chem Biol 2010, 5:265-272.
19. Huang S., Ernberg I., Kauffman S. Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective. Semin Cell Dev Biol 2009, 20:869-876.
20. Taylor I.W., Linding R., Warde-Farley D., Liu Y., Pesquita C., Faria D., Bull S., Pawson T., Morris Q., Wrana J.L. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol 2009, 27:199-203.
21. Volinia S., Galasso M., Costinean S., Tagliavini L., Gamberoni G., Drusco A., Marchesini J., Mascellani N., Sana M.E., Abu Jarour R., et al. Reprogramming of miRNA networks in cancer and leukemia. Genome Res 2010, 20:589-599.
22. Wu G., Feng X., Stein L. A human functional protein interaction network and its application to cancer data analysis. Genome Biol 2010, 11:R53.
23. Zelezniak A., Pers T.H., Soares S., Patti M.E., Patil K.R. Metabolic network topology reveals transcriptional regulatory signatures of type 2 diabetes. PLoS Comput Biol 2010, 6:e1000729.
24. Hwang D., Lee I.Y., Yoo H., Gehlenborg N., Cho J.H., Petritis B., Baxter D., Pitstick R., Young R., Spicer D., et al. A systems approach to prion disease. Mol Syst Biol 2009, 5:252.
25. Bonnet E., Tatary M., Joshi A., Michael T., Marshal K., Berks G., Van de Peer Y. Module network inference from a cancer gene expression data set identifies microRNA regulated modules. PLoS One 2010, 5:1-10.
26. Morandi E., Severini C., Quercioli D., D'Ario G., Perdichizzi S., Capri M., Farruggia G., Mascolo M.G., Horn W., Vaccari M., et al. Gene expression time-series analysis of camptothecin effects in U87-MG and DBTRG-05 glioblastoma cell lines. Mol Cancer 2008, 7:66-82.
27. Yang X., Deignan J.L., Qi H., Zhu J., Quian S., Zhong J., Torosyan G., Majid S., Falkard B., Kleinhanz R.R., et al. Validation of candidate causal genes for abdominal obesity which affect shared metabolic pathways and networks. Nat Genet 2009, 41:415-423.
28. Baranzini S.E. The genetics of autoimmune diseases: a networked perspective. Curr Opin Immunol 2009, 21:596-605.
29. Newgard C.B., Attie A.D. Getting biological about the genetics of diabetes. Nat Med 2010, 16:388-391.
30. Goh K.-I., Cusick M.E., Valle D., Childs B., Vidal M., Barabasi A.-L. The human disease network. Proc Natl Acad Sci USA 2007, 104:8685-8690.
31. Park J., Lee D.-S., Christakis N.A., Barabasi A.-L. The impact of cellular networks on disease comorbidity. Mol Syst Biol 2009, 5:262.
32. Zhong Q., Simonis N., Li Q.-R., Charloteaux B., Heuze F., Klitgord N., Tam S., Yu H., Venkatesan K., Mou D., et al. Edgetic perturbation models of human inherited disorders. Mol Syst Biol 2009, 5:321.
33. Erler J.T., Linding R. Network-based drugs and biomarkers. J Pathol 2010, 220:290-296.
34. Pawson T., Linding R. Network medicine. FEBS Lett 2008, 582:1266-1270.
35. Barabasi A.-L. Network medicine-from obesity to the " diseasome" N Engl J Med 2007, 357:404-407.
36. Simko G.I., Gyurko D., Veres D.V., Nanasi T., Csermely P. Network strategies to understand the aging process and help age-related drug design. Gen Med 2009, 1:90.
37. Hase T., Tanaka H., Suzuki Y., Nakagawa S., Kitano H. Structure of protein interaction networks and their implications on drug design. PLoS Comput Biol 2009, 5:e1000550.
38. Zimmermann G.R., Lehar J., Keith C.T. Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov Today 2007, 12:34-42.
39. Kitano H. A robustness-based approach to systems-oriented drug design. Nature 2007, 6:202-210.
40. Spiro Z., Kovacs I.A., Csermely P. Drug-therapy networks and the prediction of novel drug targets. J Biol 2008, 7:20.